Ryman Healthcare

Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and is one of the largest companies listed on the NZX 50 Index.[1][2]

Ryman Healthcare Limited
Public
Traded asNZX: RYM
ISINNZRYME0001S4 
IndustryAged care
Founded1984 founded, 1999 IPO
FounderJohn Ryder, Kevin Hickman
Headquarters
Christchurch
,
New Zealand
Areas served
NZ, Australia
Key people
CEO – Gordon MacLeod, CFO – David Bennett,
Chairman – Dr David Kerr
ProductsRetirement villages and aged care
OwnerPublic listing company (NZX)
Number of employees
5000+
Websitewww.rymanhealthcare.co.nz

Ryman Healthcare has 34 operational villages across New Zealand and two in Melbourne is developing another eight villages in Victoria, Australia. Its name is a portmanteau of its two founders, John Ryder and Kevin Hickman, who founded the company in 1984.[3]

As at July 2020, Ryman Healthcare has a market capitalisation of over $6.5 Billion NZD. It has not had to raise capital since its IPO in 1999, funding all its development from operational cash-flows.[4]

Ryman's business model is a mixture of property development and healthcare services. It operates on a "deferred management fees" model where the village resident pays for a lifetime occupancy use of their apartment or unit, and upon moving out, the resident or their estate receives a lesser sum back for their unit, capped at 20% deducted if over a five year period.

Ryman Healthcare villages offer a blend of different retirement living options at their villages, which are usually large enough to support a mini-hospital for residents and a secure dementia wing. Ryman describe this as a "continuum of care" where residents can remain in the Ryman village of choice, whether it is for independent retirement living, rest home care, dementia or hospital care.[5]

Ryman expanded into Australia in 2012, buying a site for development in Wheelers Hill, in eastern Melbourne, Victoria.[6] Ryman has since purchased another eight sites for development at Brandon Park, Burwood East, Coburg, Mt Eliza, Mt Martha, Aberfeldie, Ocean Grove and Geelong.[7]

Other notable competitors to Ryman Healthcare in the New Zealand aged care sector include Metlifecare, Oceania, BUPA, Summerset Holdings and Arvida.

Company performance

Ryman Healthcare has demonstrated significant profit and share price performance since its inception. For the last five years, it has managed earnings growth of over 15% per annum.[8] Ryman has delivered 15 years of consecutive record earnings results since 2002.[9] Ryman employs over 6000 people, including in house development teams, builders and tradespeople, nursing and caregivers, cooks, cleaners, sales and support staff. Ryman villages are home to more than 12,000 residents.

Awards

Ryman Healthcare have won a number of awards for business and healthcare, including:

  • Inclusion as one of the top 10 healthcare companies in the world in the Boston Consulting Group's Annual Value Creators Rankings[10][11]
  • Simon Challies, Ryman Healthcare's CEO, won Best CEO of 2014 in the Deloitte Top 200 Awards in 2014.[12]
  • Dr David Kerr, Ryman Healthcare's Chairman of the Board of Directors, won best Chairman in the Deloitte Top 200 Awards in 2013.
  • Reader's Digest "Most Trusted Brand New Zealand 2015, 2016, 2018, 2019, 2020."[13]
  • Workbase Best Growth Strategy Award.[14]


The Ryman Prize

In 2015 Ryman Healthcare announced it was supporting the launch of the Ryman Prize.[15]

The Ryman Prize is an annual $250,000 NZD for the best idea, innovation or advance in the world that enhances quality of life for older people. It is a philanthropic initiative administered by The Ryman Foundation. Hollows Foundation founding director Gabi Hollows won the inaugural Ryman Prize[16] for her decades of work to restore the sight of more than 1 million people with preventable blindness.

Alzheimer's Disease researcher Professor Henry Brodaty won the 2016 prize. Professor Brodaty, who lives in Sydney, is Scientia Professor of Ageing and Mental Health, the founding Director of the Dementia Collaborative Research Centre and Co-Director of CHeBA, the Centre for Healthy Brain Ageing at the University of New South Wales.[17]

The 2017 Ryman Prize went to Professor Peter St George-Hyslop. Professor St George-Hyslop is a medical scientist, neurologist and molecular geneticist who is known for his research into neurodegenerative diseases. He has identified a number of key genes that are responsible for nerve cell degeneration and early-onset forms of Alzheimer's disease. He splits his time between the University of Cambridge and the University of Toronto where he has research labs.[18] [19] [20]

Professor Takanori Shibata was awarded the 2018 Ryman Prize in recognition of his more than 25 years of ground-breaking research into new technology to help older people.

Professor Shibata, an artificial intelligence (AI) and robotics pioneer, was presented with the prize by the Right Honourable Jacinda Ardern, Prime Minister of New Zealand.

The 2019 Ryman Prize was awarded to Dr Michael Fehlings, a Canadian neurosurgeon, for his pioneering research into degenerative cervical myelopathy (DCM), a spinal disorder that affects older people. [21]

gollark: I mean, you could do that, but then nobody uses your thing.
gollark: Paid by whom? You want to charge end users capital?!
gollark: It would be nice if it was possible to make incentives for these things work.
gollark: osmarksnetnet™ operates as a mesh overlay network nowadays.
gollark: Oh, so just big directional antennas, not satelliteuous things with LNBs and whatever.

References
  1. "Living & Care Options". Ryman Healthcare. Retrieved 20 November 2012.
  2. "NZX Main Board | RYM". New Zealand Stock Exchange. Retrieved 20 November 2012.
  3. "Our History". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  4. "Creating Shareholder Value". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  5. "Continuum of Care – Resthomes, Hospital Facilities, Elderly Community | Ryman Healthcare, New Zealand". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  6. Steeman, Marta. "Ryman Healthcare cautious Aussie debut". Fairfax New Zealand Limited. Retrieved 20 November 2012.
  7. "Ryman to spend $100m on second Melbourne village". New Zealand Herald. 21 May 2014. ISSN 1170-0777. Retrieved 31 December 2015. https://www.nzx.com/companies/RYM/announcements/301156
  8. "Share Performance". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  9. "Thirteen Years of Record Results". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  10. "Ryman Healthcare achieves top 10 world ranking". 15 August 2017 – via www.nzherald.co.nz.
  11. "How Top Value Creators Outpace the Market—for Decades". www.bcg.com.
  12. "Ryman managing director wins Deloitte Top 200 award". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  13. "Trusted Brands New Zealand Ryman Healthcare Showcase". www.trustedbrands.co.nz. Retrieved 31 December 2015.
  14. "Workbase Top 200 award Ryman healthcare". workbase.org.nz. Retrieved 31 December 2015.
  16. "Gabi Hollows 'honoured' to be awarded Ryman prize" – via TVNZ.
  17. Healthcare, Ryman. "The Ryman Prize | Ryman Healthcare". www.rymanhealthcare.co.nz.
  18. Peter St George-Hyslop
  20. "Alzheimer's will be cured, but world expert can't say when". Stuff.
  21. {{https://www.cbc.ca/radio/asithappens/as-it-happens-friday-edition-1.5308978/i-feel-very-honoured-by-this-canadian-neurosurgeon-wins-ryman-prize-for-spinal-cord-research-1.5309288}}
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.